Telomerase activation in human hepatocarcinogenesis

American Journal of Gastroenterology

Volumn 101, Issue 4, 2006, Pages 839-841

  Hytiroglou, Prodromos ^a   Theise, Neil D ^b  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

CHRONIC HEPATITIS; ENZYME ACTIVATION; GENE EXPRESSION; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALIGNANT NEOPLASTIC DISEASE; PRECANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

CARCINOMA, HEPATOCELLULAR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; LIVER NEOPLASMS; TELOMERASE;

EID: 33645450751     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00521.x     Document Type: Review

References (33)

1. Harle-Bachor C Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996 93 6476 81.
2. Belair CD Yeager TR Lopez TM et al. Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997 94 13677 82.
3. Norrback KF Roos G. Telomeres and telomerase in normal and malignant hematopoietic cells. Eur J Cancer 1997 33 774 80.
4. Shay JW Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996 8 66 71.
5. Shay JW Gazdar AF. Telomerase in the early detection of cancer. Clin Pathol 1997 50 106 9.
6. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998 95 90 2.
7. Tahara H Nakanishi T Kitamoto M et al. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995 55 2734 6.
8. Nouso K Urabe Y Higashi T et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996 78 232 6.
9. Kojima H Yokosuka O Imazeki F et al. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997 112 493 500.
10. Hytiroglou P Kotoula V Thung SN et al. Telomerase activity in precancerous hepatic nodules. Cancer 1998 82 1831 8.
11. Wick M Zubov D Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 1999 232 97 106.
12. Kotoula V Hytiroglou P Pyrpasopoulou A et al. Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver 2002 22 57 69.
13. Theise ND Park YN Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002 6 497 512.
14. Hytiroglou P. Morphological changes of early human hepatocarcinogenesis. Semin Liver Dis 2004 24 65 75.
15. Kojiro M Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005 25 133 42.
16. Oh BK Kim YJ Park YN et al. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Am J Gastroenterol 2006 101 831 8.
17. Paradis V Bieche I Dargere D et al. Molecular profiling of hepatocellular carcinomas using a large-scale real-time RT-PCR approach. Determination of a molecular diagnostic index. Am J Pathol 2003 163 733 41.
18. Llovet JM Chen Y Wurmbach E et al. A molecular signature to differentiate dysplastic nodules and early hepatocellular carcinoma. Gene transcriptional profiles and immunohistochemistry analysis [abstract]. Hepatology 2005 42 suppl 1 239A.
19. Chen Y Wurmbach E Fiel MI et al. Molecular pathogenesis of early hepatocellular carcinoma in HCV-cirrhotic patients: Gene expression profiling and signaling pathway characterization [abstract]. Hepatology 2005 42 suppl 1 527A.
20. Horikawa I Barrett JC. cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J Natl Cancer Inst 2001 93 1171 3.
21. Ferber MJ Montoya DP Yu C et al. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 2003 22 3813 20.
22. Brechot-Paterlini P Saigo K Murakami Y et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 2003 22 3911 6.
23. Ulaner GA Hu JF Vu TH et al. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 1998 58 4168 72.
24. Brenner CA Wolny YM Adler RR et al. Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos. Mol Hum Reprod 1999 5 845 50.
25. Ulaner GA Hu JF Vu TH et al. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 2000 85 330 5.
26. Dhaene K Wauters J Weyn B et al. Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 2000 190 80 5.
27. Horikawa I Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003 24 1167 76.
28. Horikawa I Oshimura M Barrett JC. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 1998 22 65 72.
29. Cuthbert AP Bond J Trott DA et al. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst 1999 91 37 45.
30. Nishimoto A Miura N Horikawa I et al. Functional evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene 2001 20 828 35.
31. Klingelhutz AJ Foster SA McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996 380 79 82.
32. Takuma Y Nouso K Kobayashi Y et al. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. J Gastroenterol Hepatol 2004 19 1300 4.
33. Liu YC Chen CJ Wu HS et al. Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol 2004 30 384 90.